SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001192482-15-000014
Filing Date
2015-01-29
Accepted
2015-01-29 19:46:01
Documents
2
Period of Report
2015-01-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 8439
2 attach_2.htm EX-24 3948
  Complete submission text file 0001192482-15-000014.txt   14029
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Issuer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 34TH STREET AND CIVIC CENTER BOULEVARD PHILADELPHIA PA 19004
Business Address 34TH STREET AND CIVIC CENTER BOULEVARD PHILADELPHIA PA 19004 267-426-6957
Children's Hospital of Philadelphia Foundation (Reporting) CIK: 0001632060 (see all company filings)

State of Incorp.: PA | Fiscal Year End: 0630
Type: 3 | Act: 34 | File No.: 001-36819 | Film No.: 15560491